Precision gene editing in infant neuroblastoma: a review of nanoparticle: enabled CRISPR/Cas9 therapies
Emerging preclinical findings support the feasibility of nanoparticle-mediated CRISPR/Cas9 delivery, although direct evidence in infant neuroblastoma remains limited and the evidence for nanoparticle-mediated CRISPR/Cas9 therapy remains largely preclinical.
Samruddhi Kaknale, Ayush Ranjan, I. V. Enoch et al.
· Molecular Biology Reports · 0 citations